Clinical Trial Update: Quetiapine Augmentation for Treatment-resistant PTSD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating quetiapine augmentation for treatment-resistant PTSD; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Combat Disorders, Stress Disorders, Post-Traumatic | Phase 4 | Status: COMPLETED | Results posted: 2014-07-01